Sai Parenteral's IPO GMP today is Rs 8. Investors can use this GMP along with price band and subscription status for a better IPO review.
Listed
Mainboard IPO
SAIPARENTERALS
Sai Parenteral's IPO GMP & Allotment
Sai Parenteral’s IPO is a mainboard public issue of a pharmaceutical company engaged in the manufacturing of branded generic formulations and providing contract development and manufacturing (CDMO) services across domestic and international markets. The IPO comprises a mix of fresh issue (around ₹285 crore) and an offer for sale, with proceeds primarily aimed at capacity expansion, R&D development, debt repayment, and working capital needs. The issue opened on 24 March 2026 and closed on 27 March 2026, with a price band of ₹372–₹392 per share, attracting attention due to its presence in the growing pharmaceutical and export-focused segment. With a diversified product portfolio and improving financial performance, the company operates in a high-growth pharma sector, offering potential long-term opportunities for investors.
- IPO Price Band
- ₹372.00 - ₹392.00
- Lot Size
- 38 Shares
- Bidding Closes
- 27 Mar 2026
- Listing Date
- 02 Apr 2026
Quick Answer & Highlights
Sai Parenteral's IPO GMP Today & Key Takeaways
Last updated: 25 Mar 2026
Sai Parenteral's IPO officially listed on 02 Apr 2026 at Rs 400.00, delivering a +2.04% listing gain compared to its issue price of Rs 392.00. Pre-listing, its final recorded Grey Market Premium (GMP) was ₹8.
Sai Parenteral's IPO officially listed on 02 Apr 2026 at ₹400.00, delivering a +2.04% listing gain compared to its issue price of ₹392.00. Pre-listing, its final recorded Grey Market Premium (GMP) was ₹8.
| Key Metric | Figure | Status / Context |
|---|---|---|
| Current GMP | ₹8 | +2.04% vs upper band (25 Mar 2026) |
| Est. Listing Price | ₹400.00 | +2.04% Est. Listing Gain |
| Price Band | ₹372.00 - ₹392.00 | Mainboard IPO |
| Retail Minimum Investment | ₹14,896 | 1 Lot (38 Shares) |
| Bidding Window | 24 Mar 2026 – 27 Mar 2026 | Listed |
| Allotment & Listing Dates | Allotment: TBA | Listing: 02 Apr 2026 |
Current GMP Status
₹8
+2.04% vs upper band
Est. Listing Gain
+2.04%
Last Trend
25 Mar 2026
Listing Price
₹400.00
Retail Entry
₹14,896
IPO Details
Complete IPO information
| IPO Open Date | 24 Mar 2026 |
|---|---|
| IPO Close Date | 27 Mar 2026 |
| IPO Price Band | ₹372.00 - ₹392.00 |
| Lot Size | 38 Shares |
| Current GMP | ₹8 |
| Estimated Listing Gain | +2.04% |
| Issue Size | - |
| Fresh Issue | - |
| Issue Type | Mainboard |
| IPO Listing | NSE, BSE |
| Retail Quota | TBA |
| Registrar | TBA |
| Overall Subscription | 0.05x |
| Minimum Investment | ₹14,896 |
| DRHP Draft Prospectus | |
| RHP Draft Prospectus | - |
Analysis
IPO Snapshot & Investor Takeaways
At the upper end of its price band, Sai Parenteral's is priced at ₹392 per share. With a minimum lot size of 38 shares, a retail investor applying for one lot would need approximately ₹14,896 to participate in this Mainboard issue.
The latest recorded Grey Market Premium for Sai Parenteral's stands at ₹8, implying an estimated listing gain of around 2.04% over the issue price if it holds until listing. GMP reflects informal grey-market sentiment rather than a guaranteed outcome, and can change at any point until the day of listing.
As of the latest update, Sai Parenteral's's IPO was subscribed 0.05x overall, with a category-wise breakdown of Retail 0.03x, QIB 0x.
Mainboard IPOs list on the main platform of BSE/NSE, typically involve larger issue sizes, and draw participation across retail, HNI and institutional (QIB) investor categories.
Timeline
IPO roadmap at a glance
✓
Bidding Opens
24 Mar 2026
✓
Bidding Closes
27 Mar 2026
✓
Allotment
TBA
✓
Listing
02 Apr 2026
| Event / Milestone | Scheduled Date | Status |
|---|---|---|
| Bidding Opens | 24 Mar 2026 | Completed |
| Bidding Closes | 27 Mar 2026 | Completed |
| Allotment | TBA | Completed |
| Listing | 02 Apr 2026 | Completed |
Grey Market Premium
Daily GMP status
| Date | GMP | Change | Gain |
|---|---|---|---|
| 25 Mar 2026 | ₹0.00 | - | 0.00% |
| 23 Mar 2026 | ₹0.00 | - | 0.00% |
| 19 Mar 2026 | ₹0.00 | - | 0.00% |
Swipe to see more →
Market Lot
Application size breakdown
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 Lot | 38 | ₹14,896 |
| Retail Maximum | 13 Lot | 494 | ₹1,93,648 |
| S-HNI Minimum | 14 Lot | 532 | ₹2,08,544 |
| S-HNI Maximum | 67 Lot | 2,546 | ₹9,98,032 |
| B-HNI Minimum | 68 Lot | 2,584 | ₹10,12,928 |
Swipe to see more →
Fund Utilization
Objects of the Issue & Official Documents
Analysis
Sai Parenteral’s IPO Reservation
| Investor Category | Shares Offered | Shares (%) |
|---|---|---|
| Anchor Investor | — Shares | —% |
| QIB (Ex. Anchor) | — Shares | 50% |
| NII | — Shares | 15% |
| Retail | — Shares | 35% |
Analysis
Sai Parenteral’s IPO Anchor Investors
| Anchor Bidding Date | March 23, 2026 |
|---|---|
| Shares Offered | — Shares |
| Anchor Size | ₹ — Cr. |
| Lock-in Period (50% Shares - 30 Days) | 2026 |
| Lock-in Period (50% Shares - 90 Days) | 2026 |
Analysis
Sai Parenteral's IPO Dates
| Particular | Dates |
|---|---|
| IPO Open Date | 24 Mar 2026 |
| IPO Close Date | 27 Mar 2026 |
| Basis of Allotment | - |
| Refunds | - |
| Credit to Demat Account | - |
| IPO Listing Date | 02 Apr 2026 |
Note: The timeline for Sai Parenteral's IPO is tentative and subject to change.
Analysis
Sai Parenteral’s IPO Promoters & Holding Pattern
| Particular | Shares | % Share |
|---|---|---|
| Promoter Holding Pre Issue | 3,69,08,823 | 61.23% |
| Promoter Holding Post Issue | 4,41,79,231 | - |
| Promoters |
|---|
| Anil Kumar Karusala, Vijitha Gorrepati and Karusala Aruna |
Analysis
Sai Parenteral's Objects of the Issue & Utilisation of Proceeds
To Be Updated Soon
Analysis
About Sai Parenteral’s IPO
Sai Parenteral’s Ltd., founded in 2001, is one of the leading pharmaceutical companies focused on R&D and manufacturing of pharmaceutical products. The firm operates in 2 main business areas: makes and sells its own branded medicines, and also manufactures medicines for other companies internationally. Its product offerings include a wide range of medicines for various health conditions, like cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins, minerals, and supplements (VMS), analgesics, and dermatology.
Its medicines are available in various forms like tablets, injections, and syrups. Sai Parenteral’s major clients are government agencies, pharmaceutical companies, public and private hospitals, and large distributors in India. The firm operates 5 manufacturing facilities in India, mainly located in Hyderabad, known for developing medicines with international quality certifications.
Analysis
Sai Parenteral's Company Financials
To Be Updated Soon
Analysis
Sai Parenteral's Company Valuation – FY2026
To Be Updated Soon
Analysis
Sai Parenteral's IPO Peer Group Comparison
To Be Updated Soon
Analysis
IPO Lead Managers aka Merchant Bankers
- Arihant Capital Markets Ltd.
Comparison
Compare Sai Parenteral's IPO with similar IPOs
FAQ
Sai Parenteral's IPO FAQs
Based on the latest Grey Market Premium (GMP) of Rs 8 and an issue price of Rs 392, the estimated listing price for Sai Parenteral's IPO is Rs 400.00 (approx 2.04% listing gain). Actual listing price is determined by market demand on the listing day.
Sai Parenteral's IPO price band is Rs 372.00 to Rs 392.00. Check the latest issue price, lot size and GMP together before applying.
Sai Parenteral's IPO open date is 24 Mar 2026, close date is 27 Mar 2026, and listing date is 02 Apr 2026.
Sai Parenteral's IPO lot size is 38 shares. The minimum retail investment is Rs 14,896.
Sai Parenteral's is classified as a Mainboard IPO. This helps investors quickly understand the issue category and exchange segment.
Sai Parenteral's IPO subscription status currently shows Retail 0.03x, QIB 0x, Overall 0.05x.
Sai Parenteral’s IPO is a mainboard public issue of a pharmaceutical company engaged in the manufacturing of branded generic formulations and providing contract development and manufacturing (CDMO) services across domestic and international markets. The IPO comprises a mix of fresh issue (around ₹285 crore) and an offer for sale, with proceeds primarily aimed at capacity expansion, R&D development, debt repayment, and working capital needs. The issue opened on 24 March 2026 and closed on 27 March 2026, with a price band of ₹372–₹392 per share, attracting attention due to its presence in the growing pharmaceutical and export-focused segment. With a diversified product portfolio and improving financial performance, the company operates in a high-growth pharma sector, offering potential long-term opportunities for investors.
In our empirical study of 117 Indian IPO listings, positive GMP was followed by a positive listing gain 69.8% of the time. However, as an exact forecast, the median variation between GMP-implied gain and actual listing price was 8 percentage points. GMP reflects informal market sentiment and should always be evaluated alongside company valuation and fundamentals.
Community discussion
Comments
Share a useful question or insight about Sai Parenteral's.
Leave a comment
Your email address will not be published. All comments and replies are reviewed before appearing.
Keep Exploring
Similar Recent IPOs
Mainboard
Bombay Coated & Special Steels
Price Band₹78.00 - ₹82.00
Current GMP₹9 · +11.0%
Lot Size182 Shares
Mainboard
M.K.Sons Fine Jewels
Price Band₹153.00 - ₹162.00
Current GMP₹10 · +6.2%
Lot Size91 Shares
Mainboard
SFC Environmental Technologies
Price Band₹313.00 - ₹330.00
Current GMP₹25.1 · +4.5%
Lot Size45 Shares
Mainboard
BLS Polymers
Price Band₹142.00 - ₹150.00
Current GMP₹98 · +46.7%
Lot Size100 Shares
Loading comments...